GlassScriptPhysician profile
Andrew Axelrad
NPI 1073579876
$8,885.90
in general payments reported to CMS, 2019-2025
33 companies · $2,038 in 2025
The $2,038 reported for 2025 was more than what 79% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $500 · 2021: $489 · 2022: $1,596 · 2023: $1,421 · 2024: $1,813 · 2025: $2,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,182 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,181.96 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,453.74 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Boston Scientific Corporation | $1,880.48 | 2021-2025 | Exalt Model D, Therasphere Y90 Glass Microspheres 10 Gbq |
| Pfizer INC. | $768.74 | 2019-2025 | |
| Gilead Sciences, INC. | $639.35 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $497.34 | 2019-2025 | Entyvio |
| Janssen Biotech, INC. | $411.39 | 2019-2025 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $396.70 | 2020-2025 | Xifaxan, Trulance, Plenvu |
| Genzyme Corporation | $396.06 | 2022-2025 | |
| Celgene Corporation | $309.54 | 2021-2024 | Zeposia |
| Medtronic, INC. | $163.06 | 2022 | |
| Enterra Medical, INC. | $142.17 | 2024 | |
| Olympus America INC. | $138.44 | 2019 | |
| Daiichi Sankyo INC. | $80.82 | 2020-2023 | Injectafer |
| Amgen INC. | $75.44 | 2020-2023 | Amjevita, Avsola |
| Qol Medical, LLC | $70.42 | 2020-2025 | Sucraid |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $47.25 | 2024 | Bylvay, Iqirvo |
| Ardelyx, INC. | $47.25 | 2025 | Ibsrela |
| Madrigal Pharmaceuticals | $46.42 | 2025 | Rezdiffra |
| Ironwood Pharmaceuticals, INC | $42.85 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $34.46 | 2022-2024 | Dupixent |
| Intercept Pharmaceuticals, INC. | $27.40 | 2019-2020 | |
| Braintree Laboratories, INC. | $27.33 | 2019-2022 | |
| Fresenius Kabi USA, LLC | $26.71 | 2023 | Idacio |
| Romark Laboratories, Lc | $25.21 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.35 | 2023 | Givlaari |
| Endo Pharmaceuticals INC. | $17.07 | 2019 | |
| Nestle Healthcare Nutrition INC. | $16.83 | 2021 | |
| Echosens North America, INC. | $16.22 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.41 | 2022 | |
| Ethicon US, LLC | $14.91 | 2019 | |
| Shire North American Group INC | $13.22 | 2019 | |
| Organon LLC | $12.45 | 2021 | |
| Allergan, INC. | $11.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Axelrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.